irofulven has been researched along with Colorectal Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abbruzzese, J; Cohen, SC; George, CS; Hoff, PM; Nasta, SD; Neubauer, M; Pazdur, RM; Winn, R | 1 |
| Von Hoff, DD | 1 |
1 review(s) available for irofulven and Colorectal Neoplasms
| Article | Year |
|---|---|
Promising new agents for treatment of patients with colorectal cancer.
Topics: Adenoviridae; Antineoplastic Agents; Benzofurans; Colorectal Neoplasms; Drug Screening Assays, Antitumor; Duocarmycins; Enzyme Inhibitors; Humans; Indoles; Phenylurea Compounds; Sesquiterpenes; Thymidylate Synthase; Tumor Cells, Cultured; Urea | 1998 |
1 trial(s) available for irofulven and Colorectal Neoplasms
| Article | Year |
|---|---|
Phase II study of MGI-114 administered intravenously for 5 days every 28 days to patients with metastatic colorectal cancer.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Colorectal Neoplasms; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Metastasis; Sesquiterpenes; Survival Analysis | 2003 |